BioCentury

8:20 PM GMT, Nov 9, 2017
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

FDA approves Merck's Prevymis for CMV

FDA approved once-daily oral and IV formulations of Prevymis letermovir (MK-8228) from Merck &

Read the full 141 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.